Nonagen Bioscience Corporation is a biotechnology company developing diagnostic assays for disease detection and treatment analysis. Based upon its internal genomic and proteomic programs, Nonagen is developing assays which will offer significant improvement upon existing techniques. As of 2014, Nonagen was focusing in the fields of oncology diangostics with a urine test capable of detecting bladder cancer in development.
